VEGFA and pulmonary arterial hypertension: Experimental models provide a cogent explanation for the paradox of VEGF-receptor-blockade-induced PAH and the multiple properties of VEGF, which can be either angiogenic or nonangiogenic depending on the nature of the ligand, the receptor-dependent and -independent signaling pathways, and the duration of the ligand–receptor engagement.